SCM
MRK icon

Soleus Capital Management’s Merck MRK Stock Holding History

Soleus Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.4M Buy
+203,000
New +$23.4M 0.99% 27
2021
Q2 		– Sell
-31,551
Closed -$2.32M – 71
2021
Q1 		$2.32M Buy
31,551
+1,782
+6% +$131K 0.42% 46
2020
Q4 		$2.32M Buy
29,769
+1,914
+7% +$146K 0.31% 34
2020
Q3 		$2.21M Buy
+27,855
New +$2.18M 1.17% 30

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Soleus Capital Management's MRK Position: Q1 2026 in Review

Soleus Capital Management opened a new position in Merck (MRK) in Q1 2026: 203,000 shares worth $24.4M. The stake represents 0.99% of the portfolio and ranks #27 among its holdings. This is a return to the name: Soleus Capital Management previously reported a position in MRK as recently as Q1 2021.

Soleus Capital Management first reported a position in MRK in Q3 2020 and has held it in 4 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Soleus Capital Management held 203,000 shares of Merck worth $24.4M as of Q1 2026.
  • Merck was a new Soleus Capital Management position in Q1 2026.
  • Merck made up 0.99% of Soleus Capital Management's portfolio in Q1 2026, its #27 holding.
  • Soleus Capital Management first reported a position in Merck in Q3 2020 and has held it in 4 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.